|
Formulary
Click on article title to view & purchase. Articles are sorted by their publication date in reverse chronological order.
Taxotere Injection Concentrate.(Priority review)(Brief article) August 01, 2007
Isentress.(Fast-track designation)(Brief article) August 01, 2007
Exenatide associated with sustained blood glucose control, weight loss... August 01, 2007
Nebivolol demonstrates neutral effect on glucose levels.(Meeting Cover... August 01, 2007
FDA advisory panel votes to keep rosiglitazone on market, but not with... August 01, 2007
Botulinum toxin type A.(Selected literature)(Brief article) August 01, 2007
Farinelli I, Coloprisco G, De Filippis S, Martelletti P. Long-term ben... August 01, 2007
Selected websites.(Drug Watch: A HEADS-UP ON PHARMACEUTICALS IN LATE-S... August 01, 2007
Acute pain and migraine/headache.(Drug Watch: A HEADS-UP ON PHARMACEUT... August 01, 2007
Zimulti.(NDA withdrawn)(Brief article) August 01, 2007
Intuniv.(Approvable designations)(Brief article) August 01, 2007
Risperdal.(Approvable designations)(Brief article) August 01, 2007
Thelin.(Approvable designations)(Brief article) August 01, 2007
HCV-796 (ViroPharma) for the treatment of hepatitis C virus.(Fast-trac... August 01, 2007
Hycamtin.(Priority review)(Brief article) August 01, 2007
Ixabepilone (Bristol-Myers Squibb) as monotherapy for the treatment of... August 01, 2007
Erbitux.(Priority review)(Brief article) August 01, 2007
Multikine.(Orphan drug designations)(Brief article) August 01, 2007
Immtech.(Orphan drug designations)(Brief article) August 01, 2007
Altus.(Orphan drug designation revocation)(Brief article) August 01, 2007
First-time generic approvals.(FDA Drug Approvals)(Brief article) August 01, 2007
Nuvigil.(FDA actions in brief)(Brief article) August 01, 2007
Endometrin Vaginal Insert.(FDA actions in brief)(Brief article) August 01, 2007
Carnitor SF.(FDA actions in brief)(Brief article) August 01, 2007
Apidra.(FDA actions in brief)(Brief article) August 01, 2007
Lexiva.(FDA actions in brief)(Brief article) August 01, 2007
Differin Gel, 0.3%.(FDA actions in brief)(Brief article) August 01, 2007
Extina.(FDA actions in brief)(Brief article) August 01, 2007
Copaxone.(FDA actions in brief)(Brief article) August 01, 2007
FazaClo Orally Disintegrating Tablets.(FDA actions in brief)(Brief art... August 01, 2007
Interim analysis of RECORD trial provides inconclusive data regarding ... August 01, 2007
DAD study: use of protease inhibitors increases risk of myocardial inf... August 01, 2007
Actos.(Safety labeling updates & new warnings)(Brief article) August 01, 2007
RotaTeq.(Safety labeling updates & new warnings)(Brief article) August 01, 2007
Rocephin for Injection.(Safety labeling updates & new warnings)(Brief ... August 01, 2007
Dr von Eschenbach's vision: FDA's newest commissioner faces multiple c... August 01, 2007
Drug utilization by enrollees in Medicare plans in 2006 *.(Drug and Fo... August 01, 2007
Top therapeutic classes contributing to projected spending growth, 200... August 01, 2007
Antidepressant use and expenditures, 1997 vs 2004 *.(Formulary factoid... August 01, 2007
Antipsychotic use and expenditures, 1997 vs 2004 *.(Formulary factoids... August 01, 2007
44%.(Formulary factoids)(percentage of Americans who use at least one ... August 01, 2007
Vernakalant: a novel antiarrhythmic agent for the treatment of atrial ... August 01, 2007
HORIZON: yearly infusion of zoledronic acid reduces risk of fracture i... August 01, 2007
ADAPT: naproxen and celecoxib demonstrated to be ineffective in primar... August 01, 2007
Budesonide plus formoterol associated with better control of persisten... August 01, 2007
LOCSS trial: once-daily fluticasone plus salmeterol superior to montel... August 01, 2007
Bare-metal and drug-eluting stents yield similar cardiac event risks, ... August 01, 2007
Lamotrigine, valproate emerge as superior epilepsy treatment options a... August 01, 2007
Patients with cancer and ACS, with or without thrombocytopenia, may be... August 01, 2007
SOLAR: initial rosuvastatin superior to atorvastatin, simvastatin for ... August 01, 2007
Researchers debate the CV safety of rosiglitazone: from the 67th Annua... August 01, 2007
PROactive: pioglitazone improves CV outcomes in patients with renal dy... August 01, 2007
Lipid-lowering therapies reduce development of peripheral neuropathy.(... August 01, 2007
Quick-release bromocriptine has favorable cardiovascular safety profil... August 01, 2007
Pulmonary effects of inhaled insulin are small, reversible.(Meeting Co... August 01, 2007
Sumatriptan plus naproxen reduces traditional and nontraditional migra... August 01, 2007
Debate about rosiglitazone safety prompts hearing in House; FDA seeks ... August 01, 2007
Frovatriptan.(Selected literature)(Brief article) August 01, 2007
Sumatriptan/naproxen.(Selected literature)(Brief article) August 01, 2007
Smith T, Blumenthal H, Diamond M, et al. Sumatriptan/naproxen sodium f... August 01, 2007
Maraviroc (Pfizer) as therapy for treatment-experienced patients infec... August 01, 2007
Letairis: Ambrisentan.(New molecular entity) August 01, 2007
Exforge: Amlodipine/valsartan.(New combination) August 01, 2007
Lyrica: Pregabalin.(New indication) August 01, 2007
|